A Case of Lung Adenocarcinoma Harboring <i>EGFR</i> Exon19 Deletion/Insertion Mutation Detected by Next-Generation Sequencing (NGS), but Not by PCR

Lung Adenocarcinoma ◽

Insertion Mutation ◽

Next Generation ◽

Comprehensive assessment of targetable alterations in lung adenocarcinoma samples with limited material using MSK-IMPACT, a clinical, hybrid capture-based, next-generation sequencing (NGS) assay.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e22160 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e22160-e22160 ◽

Cited By ~ 3

Author(s):

Maria E. Arcila ◽

Helena Alexandra Yu ◽

Alexander E. Drilon ◽

Gregory J. Riely ◽

Ahmet Zehir ◽

...

Keyword(s):

Lung Adenocarcinoma ◽

Comprehensive Assessment ◽

Next Generation ◽

Hybrid Capture ◽

Next generation sequencing (NGS) in lung adenocarcinoma (LA) as a guide to treatment selection.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.9084 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 9084-9084

Author(s):

Emmet Jordan ◽

David Barron ◽

Nikolaus Schultz ◽

Debyani Chakravarty ◽

Mark G. Kris ◽

...

Keyword(s):

Lung Adenocarcinoma ◽

Treatment Selection ◽

Next Generation ◽

Next Generation Sequencing (Ngs) Reveals Qualitative and Quantitative Molecular Heterogeneity Within Egfr-Mutant Advanced Lung Adenocarcinoma (Ala) Patients (Pts) Receiving Gefitinib (G)

Annals of Oncology ◽

10.1093/annonc/mdu349.90 ◽

2014 ◽

Vol 25 ◽

pp. iv462

Author(s):

E. Bria ◽

S. Pilotto ◽

E. Amato ◽

M. Fassan ◽

S. Novello ◽

...

Keyword(s):

Lung Adenocarcinoma ◽

Molecular Heterogeneity ◽

Next Generation ◽

Qualitative And Quantitative ◽

Egfr Mutant ◽

P2.14-38 ATAD2B-ALK, a Novel Fusion in Lung Adenocarcinoma Identified Using Next-Generation Sequencing (NGS)

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.08.1823 ◽

2019 ◽

Vol 14 (10) ◽

pp. S844 ◽

Cited By ~ 1

Author(s):

H. Bai ◽

W. Jia ◽

X. Jin ◽

H. Mao ◽

D. Wu ◽

...

Keyword(s):

Lung Adenocarcinoma ◽

Next Generation ◽

Identification of new familial pheochromocytoma/paraganglioma genes using next generation sequencing (NGS)

Endocrine Abstracts ◽

10.1530/endoabs.40.l12 ◽

2016 ◽

Author(s):

Alberto Cascon

Keyword(s):

Next Generation ◽

Familial Pheochromocytoma ◽

Difference in plasma miRNA levels in inferior petrosal sinus samples from patients with ACTH-dependent Cushing’s syndrome as assessed by next-generation sequencing (NGS).

Endocrine Abstracts ◽

10.1530/endoabs.70.aep569 ◽

2020 ◽

Author(s):

Zhanna Belaya ◽

Anastasia Malygina ◽

Alexey Nikitin ◽

Philipp Koshkin ◽

Ivan Sitkin ◽

...

Keyword(s):

Cushing’S Syndrome ◽

Cushing's Syndrome ◽

Inferior Petrosal Sinus ◽

Next Generation ◽

Plasma Mirna ◽

Comprehensive comparison of trophectoderm (TE) and inner cell mass (ICM) by next generation sequencing (NGS)

10.26226/morressier.5af300b2738ab10027aa98b3 ◽

2018 ◽

Author(s):

Ibrahim Elkhatib ◽

Ibrahim ['Alberto']

Keyword(s):

Inner Cell Mass ◽

Cell Mass ◽

Next Generation ◽

Comprehensive Comparison ◽

Next-generation sequencing (NGS) based preimplantation genetic testing for products of reciprocal translocation (PGT-TR) improves diagnosis of the patients by verification of their classical karyotyping results.

10.26226/morressier.5af300b2738ab10027aa98a4 ◽

2018 ◽

Author(s):

Sebastian Pukszta

Keyword(s):

Genetic Testing ◽

Reciprocal Translocation ◽

Next Generation ◽

Preimplantation Genetic Testing ◽

Initial Next-Generation Sequencing (NGS) Results of Alport Syndrome

Journal of Basic and Clinical Health Sciences ◽

10.30621/jbachs.2019.719 ◽

2019 ◽

Author(s):

Altuğ Koç ◽

Elçin Bora ◽

Tayfun Cinleti ◽

Gizem Yıldız ◽

Meral Torun Bayram ◽

...

Keyword(s):

Alport Syndrome ◽

Next Generation ◽

Next Generation Sequencing（NGS）Monitors Minimal Residual Disease（MRD）in Allo-PBSCT Patients

Case Medical Research ◽

10.31525/ct1-nct04126967 ◽

2019 ◽

Author(s):

Keyword(s):

Minimal Residual Disease ◽

Residual Disease ◽

Next Generation ◽

Generation Sequencing ◽

Minimal Residual